{"product_id":"uw-medicine-comprehensive-hematology-amp-oncology-review-2024","title":"UW Medicine Comprehensive Hematology \u0026amp; Oncology Review 2024","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch3\u003eUW Medicine Comprehensive Hematology \u0026amp; Oncology Review 2024\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e Include: 54 videos + 55 pdfs, size: 40.3 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Target Audience: physicians, advanced practice providers, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location: Monday, September 23, 2024, 7:15 AM – Friday, September 27, 2024, 5:00 PM, Other, Seattle, WA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Hematology, Oncology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Non-Physician, Nurse, Nurse Practitioner, Physician, Physician Associate\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eOverview\u003c\/div\u003e\n\u003cp\u003eThis 54-topic program covers data supporting guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and hematologic disorders. After completing the program, learners will have a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors, hematologic disorders and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.. The material can be used to help prepare attendees for certifying and re-certifying exams.\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.\u003c\/li\u003e\n\u003cli\u003eExplain the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.\u003c\/li\u003e\n\u003cli\u003eIntegrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.\u003c\/li\u003e\n\u003cli\u003eOrganize new therapeutic and diagnostic approaches into clinical practice as appropriate.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"Grid__row___qCQ9V Grid__small___AMx35\"\u003e\n\u003cdiv class=\"Grid__column___NWQ7M Grid__col_12___pjiIR Grid__small___AMx35\"\u003e\n\u003cdiv id=\"widget:853a10bf-075a-489b-a235-12a4d6a3784f\" class=\"Content__widgetIdcontainer___1ace\" data-cvent-id=\"widget-content-NucleusText\"\u003e\n\u003cdiv class=\"Text__container___g_YuZ expanded\" data-cvent-id=\"widget-NucleusText-widget:853a10bf-075a-489b-a235-12a4d6a3784f\"\u003e\n\u003cdiv class=\"slight css-87ndg2\"\u003e\n\u003cdiv class=\"css-vsf5of\"\u003e\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eIntended Audience:\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"Grid__row___qCQ9V Grid__small___AMx35\"\u003e\n\u003cdiv class=\"Grid__column___NWQ7M Grid__col_12___pjiIR Grid__small___AMx35\"\u003e\n\u003cdiv id=\"widget:522948b8-693e-4f43-880d-1d3246364883\" class=\"Content__widgetIdcontainer___1ace\" data-cvent-id=\"widget-content-NucleusText\"\u003e\n\u003cdiv class=\"Text__container___g_YuZ expanded\" data-cvent-id=\"widget-NucleusText-widget:522948b8-693e-4f43-880d-1d3246364883\"\u003e\n\u003cdiv class=\"css-87ndg2\"\u003e\n\u003cdiv class=\"css-vsf5of\"\u003e\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eThis educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAcute Lymphoblastic Leukemia.mp4\u003cbr\u003e\nAcute Lymphoblastic Leukemia.pdf\u003cbr\u003e\nAcute Myeloid Leukemia.mp4\u003cbr\u003e\nAcute Myeloid Leukemia.pdf\u003cbr\u003e\nAdjuvant Therapy for Breast Cancer.mp4\u003cbr\u003e\nAdjuvant Therapy for Breast Cancer.pdf\u003cbr\u003e\nAnal Cancer.mp4\u003cbr\u003e\nAnal Cancer.pdf\u003cbr\u003e\nB-NHL, Aggressive Non-Hodgkin Lymphoma.mp4\u003cbr\u003e\nB-NHL, Aggressive Non-Hodgkin Lymphoma.pdf\u003cbr\u003e\nB-NHL, Indolent Non-Hodgkin Lymphoma.mp4\u003cbr\u003e\nB-NHL, Indolent Non-Hodgkin Lymphoma.pdf\u003cbr\u003e\nBenign White Cell Disorders.mp4\u003cbr\u003e\nBenign White Cell Disorders.pdf\u003cbr\u003e\nBladder Cancer.mp4\u003cbr\u003e\nBladder Cancer.pdf\u003cbr\u003e\nBleeding Disorders.mp4\u003cbr\u003e\nBleeding Disorders.pdf\u003cbr\u003e\nCholangiocarcinoma.mp4\u003cbr\u003e\nCholangiocarcinoma.pdf\u003cbr\u003e\nChronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) \u0026amp; Hairy Cell Leukemia.mp4\u003cbr\u003e\nChronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) \u0026amp; Hairy Cell Leukemia.pdf\u003cbr\u003e\nChronic Myeloid Leukemia.mp4\u003cbr\u003e\nChronic Myeloid Leukemia.pdf\u003cbr\u003e\nCNS Cancers.mp4\u003cbr\u003e\nCNS Cancers.pdf\u003cbr\u003e\nColorectal Cancer.mp4\u003cbr\u003e\nColorectal Cancer.pdf\u003cbr\u003e\nConsultative Hematology.mp4\u003cbr\u003e\nConsultative Hematology.pdf\u003cbr\u003e\nEsophageal Gastric Cancer.mp4\u003cbr\u003e\nEsophageal Gastric Cancer.pdf\u003cbr\u003e\nFamilial Syndromes.mp4\u003cbr\u003e\nFamilial Syndromes.pdf\u003cbr\u003e\nGastrointestinal Neuroendocrine Tumors.mp4\u003cbr\u003e\nGastrointestinal Neuroendocrine Tumors.pdf\u003cbr\u003e\nGynecologic Oncology – Cervical and Endometrial Cancers.mp4\u003cbr\u003e\nGynecologic Oncology – Cervical and Endometrial Cancers.pdf\u003cbr\u003e\nGynecologic Oncology – Ovarian Cancer.mp4\u003cbr\u003e\nGynecologic Oncology – Ovarian Cancer.pdf\u003cbr\u003e\nHead, Neck and Thyroid Cancer.mp4\u003cbr\u003e\nHead, Neck and Thyroid Cancer.pdf\u003cbr\u003e\nHematology Pharmacology Pearls.mp4\u003cbr\u003e\nHematology Pharmacology Pearls.pdf\u003cbr\u003e\nHematopoietic Cell Transplantation.mp4\u003cbr\u003e\nHematopoietic Cell Transplantation.pdf\u003cbr\u003e\nHepatocellular Cancer.mp4\u003cbr\u003e\nHepatocellular Cancer.pdf\u003cbr\u003e\nHodgkin Lymphoma.mp4\u003cbr\u003e\nHodgkin Lymphoma.pdf\u003cbr\u003e\nInfectious Disease Complications.mp4\u003cbr\u003e\nInfectious Disease Complications.pdf\u003cbr\u003e\nInherited \u0026amp; Acquired Marrow Failure.mp4\u003cbr\u003e\nInherited \u0026amp; Acquired Marrow Failure.pdf\u003cbr\u003e\nIntegrative Medicine.mp4\u003cbr\u003e\nIntegrative Medicine.pdf\u003cbr\u003e\nIron Metabolism Disorders \u0026amp; Hemolytic Anemias.mp4\u003cbr\u003e\nIron Metabolism Disorders \u0026amp; Hemolytic Anemias.pdf\u003cbr\u003e\nMelanoma and other Skin Cancers.mp4\u003cbr\u003e\nMelanoma and other Skin Cancers.pdf\u003cbr\u003e\nMesothelioma.mp4\u003cbr\u003e\nMesothelioma.pdf\u003cbr\u003e\nMetastatic Breast Cancer.mp4\u003cbr\u003e\nMetastatic Breast Cancer.pdf\u003cbr\u003e\nMOC Questions.pdf\u003cbr\u003e\nMyelodysplastic Syndromes.mp4\u003cbr\u003e\nMyelodysplastic Syndromes.pdf\u003cbr\u003e\nMyeloproliferative Neoplasms.mp4\u003cbr\u003e\nMyeloproliferative Neoplasms.pdf\u003cbr\u003e\nNewly-Diagnosed Myeloma.mp4\u003cbr\u003e\nNewly-Diagnosed Myeloma.pdf\u003cbr\u003e\nNon-Small Cell Lung Cancer – Adjuvant Locally Advanced.mp4\u003cbr\u003e\nNon-Small Cell Lung Cancer – Adjuvant Locally Advanced.pdf\u003cbr\u003e\nNon-Small Cell Lung Cancer – Metastatic.mp4\u003cbr\u003e\nNon-Small Cell Lung Cancer – Metastatic.pdf\u003cbr\u003e\nPancreatic Cancer.mp4\u003cbr\u003e\nPancreatic Cancer.pdf\u003cbr\u003e\nProstate Cancer.mp4\u003cbr\u003e\nProstate Cancer.pdf\u003cbr\u003e\nRadiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative].mp4\u003cbr\u003e\nRadiation Oncology – Multi-Disciplinary [Breast, Lung, Colorectal, and Palliative].pdf\u003cbr\u003e\nRelapsed Refractory Myeloma \u0026amp; Amyloidosis.mp4\u003cbr\u003e\nRelapsed Refractory Myeloma \u0026amp; Amyloidosis.pdf\u003cbr\u003e\nRenal Cell Carcinoma.mp4\u003cbr\u003e\nRenal Cell Carcinoma.pdf\u003cbr\u003e\nSarcoma.mp4\u003cbr\u003e\nSarcoma.pdf\u003cbr\u003e\nSmall Cell Lung Cancer.mp4\u003cbr\u003e\nSmall Cell Lung Cancer.pdf\u003cbr\u003e\nSmoldering Myeloma \u0026amp; MGUS.mp4\u003cbr\u003e\nSmoldering Myeloma \u0026amp; MGUS.pdf\u003cbr\u003e\nSolid Tumor Pharmacology Pearls.mp4\u003cbr\u003e\nSolid Tumor Pharmacology Pearls.pdf\u003cbr\u003e\nSupportive Care.mp4\u003cbr\u003e\nSupportive Care.pdf\u003cbr\u003e\nT-Cell Lymphoma – NHL.mp4\u003cbr\u003e\nT-Cell Lymphoma – NHL.pdf\u003cbr\u003e\nTesticular Cancer.mp4\u003cbr\u003e\nTesticular Cancer.pdf\u003cbr\u003e\nThalassemia \u0026amp; Hemoglobinopathies.mp4\u003cbr\u003e\nThalassemia \u0026amp; Hemoglobinopathies.pdf\u003cbr\u003e\nTherapy for Non-Invasive Breast Cancer.mp4\u003cbr\u003e\nTherapy for Non-Invasive Breast Cancer.pdf\u003cbr\u003e\nThrombocytopenia.mp4\u003cbr\u003e\nThrombocytopenia.pdf\u003cbr\u003e\nThrombosis \u0026amp; Anticoagulation.mp4\u003cbr\u003e\nThrombosis \u0026amp; Anticoagulation.pdf\u003cbr\u003e\nTransfusion Medicine.mp4\u003cbr\u003e\nTransfusion Medicine.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954576527458,"sku":"MED-AMB06466","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UW-Medicine-Comprehensive-Hematology-Oncology-Review-2024.jpg?v=1779380053","url":"https:\/\/meducourse.com\/products\/uw-medicine-comprehensive-hematology-amp-oncology-review-2024","provider":"Meducourse","version":"1.0","type":"link"}